Acquisition Context The company was acquired by Wake Research Associates, indicating a potential channel shift and integration with larger CRO networks. This presents an opportunity to re-engage on-boarding services, data transfer processes, and alignment with Wake’s client base.

Clinical Scale With multiple sites and more than 16 years in operation, the center demonstrates established enrollment capability and operational reliability, suggesting opportunities to upsell enrollment optimization, patient recruitment services, and cross-site trial coordination for sponsors.

Tech Stack Existing tools such as DocuSign, PHP, Google Analytics, and cross-training focus indicate readiness for digital trial workflows, eConsent workflows, and analytics-driven site performance dashboards to improve sponsor feasibility and data capture.

Financial Footprint Reported revenue between one and ten million dollars signals a mid-market CRO footprint suitable for expanding mid-scale trial engagements, fast-track budgets, and flexible contracting for sponsors seeking reliable sites with steady throughput.

Competitive Positioning As one of Nevada’s larger clinical research sites historically, the center can be pitched for regional access advantage, faster patient reach, and potential co-management with larger CROs to cover geographic coverage in the western United States.